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ABSTRACT
Histone covalent modifications and 26S protea-
some-mediated proteolysis modulate many reg-
ulatory events in eukaryotes. In Saccharomyces
cerevisiae, heterochromatin mediates transcrip-
tional silencing at telomeres, HM loci and rDNA
array. Here, we show that proteasome-associated
Sem1p and its interacting partner, Ubp6p (a deubi-
quitinating enzyme), are essential to maintain telo-
meric silencing. Simultaneous deletion of SEM1
and UBP6 induces dramatic silencing defect
accompanied by significantly increased level of
ubiquitinated-histone H2B and markedly reduced
levels of acetylated-lysine 14 and 23 on histone
H3 at the telomeres. Further, the loss of Sem1p
and Ubp6p triggers relocation of silencing factors
(e.g. Sir proteins) from telomere to HM loci
and rDNA array. Such relocation of silencing fac-
tors enhances gene silencing at HM loci and
rDNA array, but diminishes telomeric silencing.
Interestingly, both Sem1p and Ubp6p participate
in the proteolytic function of the proteasome.
However, we find that the telomeric silencing is
not influenced by proteolysis. Taken together, our
data demonstrate that Sem1p and Ubp6p maintain
telomeric heterochromatin structure (and hence
silencing) through modulation of histone covalent
modifications and association of silencing factors
independently of the proteolytic function of the
proteasome, thus offering a new regulatory mech-
anism of telomeric silencing.
INTRODUCTION
In Saccharomyces cerevisiae, genes in three distinct geno-
mic regions: telomeres, mating-type loci (HMR and HML)
and rDNA array, are transcriptionally silenced in a non-
speciﬁc fashion. Establishment of silencing requires forma-
tion of silent chromatin and the proper function of the
silent information regulatory (SIR) complex composed of
Sir2p, Sir3p and Sir4p (1,2). This locus-speciﬁc silencing is
known to be sensitive to the status changes in methylation,
acetylation and ubiquitination of the core histones (3–5).
These changes alter the binding of silencing proteins to
chromatin. Many histone modiﬁcation enzymes, such as
Set1p, Dot1p, Ubp10p and Rad6p, have been shown
to be involved in silencing. Rad6p, an E2 ubiquitin-
conjugating enzyme, functions together with E3 ubiquitin
ligase Bre1p to attach ubiquitin to lysine 123 (K123) of
histone H2B (4–7). H2B ubiquitination is required for
functions of Set1p and Dot1p (8–10). Set1p methylates
K4 in histone H3N-terminal tail (4–6,11), while Dot1p
methylates K79 in the core domain of histone H3
(4–6,12). Simultaneous deletion of DOT1 and SET1 signif-
icantly reduces the binding of Sir proteins to telomeres,
indicating that these two modiﬁcations function together
to mediate silencing. Recently, a deubiquitinating enzyme
Ubp10p was found to be involved in silencing (13,14).
Either ubp10D or mutation in the catalytic domain of
Ubp10p results in reduced silencing, especially at telo-
meres. Ubp10p has been implicated to participate in H2B
deubiquitination which inﬂuences H3K4 and H3K79
methylation in silent chromatin regions (13,14). Thus, a
delicate equilibrium between H2B ubiquitination and deu-
biquitination iscriticalforestablishing methylationpattern
of H3K4 and H3K79 in silent chromatin domains.
Several studies implicate acetylation of lysine residues
on histone N-terminal tails to transcriptional activation
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silent chromatin. The status of histone acetylation is con-
trolled by a dynamic equilibrium between histone acetyl-
transferases (HATs) and histone deacetylases (HDACs).
Many enzymes modulating the status of histone acetyla-
tion, such as Esa1p, Sas2p, Sir2p and Hat1p, contribute
to silencing in budding yeast (15–18). Among the four
acetylable lysines in the N-terminal tail of histone H4,
only mutation of H4K16 signiﬁcantly aﬀects telomeric
silencing (19). Among the ﬁve acetylable lysine residues
in the N-terminal tail of histone H3, K14 and K23
(H3K14/K23) are more important than K9 or K18 in
telomeric silencing (17). Recently, Taverna et al. (20)
have shown that histone H3 K14 acetylation is correlated
with histone H2B ubiquitination via H3 K4 methylation.
Thus, the enzymes involved in histone H2B deubiquitina-
tion can potentially regulate telomeric silencing.
Ubp6p is one of the two deubiquitinating enzymes asso-
ciated with the ‘lid’ subcomplex of the 26S proteasome
(1,21–25). Association of Ubp6p with the proteasome is
critical for the deubiquitinating activity of Ubp6p (26) and
for the half-life of ubiquitin (27). Although the exact roles
of Ubp6p remain to be discovered, it is widely believed
that Ubp6p is involved in proteasome-mediated protein
degradation (22,28). Notably, aﬃnity capture-MS has
identiﬁed the physical interaction between Ubp6p and
Sem1p, a subunit of the 26S proteasome lid subcomplex
(21). Thus, Ubp6p and Sem1p form a structural module
with the lid subcomplex of the proteasome. Like Ubp6p,
Sem1p is involved in proteasome-dependent proteolysis
(29). Further, Sem1p has been shown to be required for
DNA double-strand break repair (29).
Several lines of evidence indicate that H2B deubiquiti-
nation is important in the maintenance of heterochroma-
tin structure at telomeres, and hence telomeric silencing.
Therefore, H2B deubiquitinating enzymes are potential
regulators of telomeric silencing. Recent studies (13,14)
have implicated a H2B ubiquitin protease Ubp10p,
but not SAGA-associated Ubp8p, in controlling H2B
ubiquitination at the telomere. However, the role of the
proteasome-associated Ubp6p in regulation of H2B ubi-
quitination and gene expression at telomere has not yet
been analyzed, even though a large number of studies (30)
have implicated proteasome in transcriptional regulation.
Here, we have analyzed whether Ubp6p is involved in
H2B deubiquitination and telomeric silencing. Our data
demonstrate that Ubp6p in conjunction with Sem1p par-
ticipates in telomeric silencing by promoting histone H2B
deubiquitination, H3 acetylation and association of silen-
cing factors. Further, we show that Sem1p and Ubp6p
maintain telomeric silencing independently of the proteo-
lytic function of the proteasome. Thus, these two proteins
perform two distinct functions (i.e. heterochromatin main-
tenance and protein degradation) in separate pathways.
MATERIALS AND METHODS
Yeaststrains
Genotypes of yeast strains used in this study are described
in Table 1. Yeast genetic manipulation was performed
following standard methods. Deletion mutant strains
were generated via PCR-mediated gene disruption
method as previously described (31), and were conﬁrmed
by PCR analysis. Multiple myc-epitope tags were added at
the C-terminals of Sem1p, Ubp6p and Sir2p as described
previously (32,33), and were conﬁrmed by PCR and west-
ern blot analyses.
Spot test assay
Spot tests were done essentially the same as previously
described with minor changes (17,25). Five-milliliter
yeast cultures were grown overnight at 308C. For each
strain 5 10
7cells were resuspended in 200ml of distilled
water. Ten-fold serial dilutions of the cell suspensions
were made, and 10ml of each dilution was spotted onto
synthetic complete (SC) plates, synthetic complete plates
containing 0.1% 5-ﬂuoroorotic acid (SC+FOA). These
plates were incubated at 308C for 3 to 7 days, and photo-
graphs were then taken with a digital camera.
Western blotting
Whole-cell extracts were prepared as previously described
with minor modiﬁcations (34). Brieﬂy, 50-ml cultures were
grown overnight at 308C to mid-log phase. Cells were
harvested by centrifugation and then lyzed in 200mlo f
SUME buﬀer (1% sodium dodecyl sulfate, 8M urea,
10mM morpholino-propane-sulfonic acid, pH 6.8,
10mM EDTA) by vortexing with acid-washed glass
beads. For each sample 25mgo r5 0 mg of total protein
was resolved by SDS–PAGE. Resolved SDS–PAGE gels
were transferred onto nitrocellulose membranes, and pro-
teins were analyzed with appropriate primary and second-
ary antibodies. For quantitation, ﬁlms were scanned, and
protein bands were quantitated with Alpha Imager 2000
software.
Reverse transcriptase-polymerase chain reaction (RT-PCR)
RT-PCR was performed essentially as previously
described with minor modiﬁcations (24). The Pdr5i
strain that is capable of uptaking MG132 were generated,
and used for preparing mRNA by standard TriZol-based
RNA extraction protocol. Total mRNA (200ng) and 10
pmol of oligo (dT) primer were used to generate comple-
mentary DNA (cDNA) by RT (Invitrogen). Ten percent
of the cDNA products were then used for 20 to 25 cycles
of PCR. PCR products were resolved on 2% agarose gels,
which were then photographed. DNA bands were quanti-
tated with Alpha Imager 2000 software. Primer sequences
are available upon request.
Chromatin immunoprecipitation (ChIP) and sequential
chromatin immunoprecipitation (SeqChIP) assays
Except for minor protocol modiﬁcations, ChIP and
SeqChIP assays were performed essentially as previously
described (33). For ChIP, 50-ml yeast cultures were
incubated overnight at 308C in YPD (yeast extract, pep-
tone plus dextrose), and grown upto an OD600 of  0.8.
Cells were ﬁxed by adding formaldehyde (1% ﬁnal con-
centration) and collected by centrifugation. Fixed cells
1844 Nucleic Acids Research, 2009, Vol. 37,No. 6were washed, lyzed and sonicated to generate DNA
fragments in the range of 500–800bp. Anti-myc antibody
was used to immunoprecipitate myc-tagged Sem1p,
Ubp6p and Sir2p. For SeqChIP, 500-ml yeast cultures
were grown overnight in YPD upto an OD600 of  0.8.
Cells were then ﬁxed, lyzed and sonicated to generate
DNA fragments in the range of 500–800bp as described
above. Chromatin was then isolated and incubated
with an anti-Flag antibody (Sigma, M5) and protein
A-Sepharose. Precipitated protein complexes were
Table 1. Relevant yeast strains
Strain Genotype Reference or
source
BY4705a MAT  ade2D::hisG his3D200 leu2D0 lys2D0 met15D0 trp1D63 ura3D0 (31)
SQY1002 MAT  ade2D::hisG his3D200 leu2D0 lys2D0 met15D0 trp1D63 ura3D0 sem1::HIS3 This study
SQY1079 MAT  ade2D::hisG his3D200 leu2D0 lys2D0 met15D0 trp1D63 ura3D0 sem1::HIS ubp6::URA3 This study
SQY1084 MAT  ade2D::hisG his3D200 leu2D0 lys2D0 met15D0 trp1D63 ura3D0 UBP6::13myc::TRP1 This study
SQY1085 MAT  ade2D::hisG his3D200 leu2D0 lys2D0 met15D0 trp1D63 ura3D0 SEM1::13myc::TRP1 This study
SQY1090 MAT  ade2D::hisG his3D200 leu2D0 lys2D0 met15D0 trp1D63 ura3D0 SIR2::13myc::TRP1 This study
SQY1091 MAT  ade2D::hisG his3D200 leu2D0 lys2D0 met15D0 trp1D63 ura3D0 sem1::HIS3 ubp6::URA3
SIR2::13myc::TRP1
This study
UCC606 MAT  ade2D::hisG his3D200 leu2D0 lys2D0 met15D0 trp1D63 ura3D0 ADE2-TEL-VR URA3-TEL-VIIL Gottschling
SQY1012 MAT  ade2D::hisG his3D200 leu2D0 lys2D0 met15D0 trp1D63 ura3D0 ADE2-TEL-VR URA3-TEL-VIIL
sem1::TRP1
This study
SQY1039 MAT  ade2D::hisG his3D200 leu2D0 lys2D0 met15D0 trp1D63 ura3D0 ADE2-TEL-VR URA3-TEL-VIIL
ubp6::HIS3
This study
SQY1040 MAT  ade2D::hisG his3D200 leu2D0 lys2D0 met15D0 trp1D63 ura3D0 ADE2-TEL-VR URA3-TEL-VIIL
sem1::TRP1 ubp6::HIS3
This study
SQY1046 MAT  ade2D::hisG his3D200 leu2D0 lys2D0 met15D0 trp1D63 ura3D0 ADE2-TEL-VR URA3-TEL-VIIL
sir2::HIS3
This study
SQY1048 MAT  ade2D::hisG his3D200 leu2D0 lys2D0 met15D0 trp1D63 ura3D0 ADE2-TEL-VR URA3-TEL-VIIL
ubp10::HIS3
This study
SQY1050 MAT  ade2D::hisG his3D200 leu2D0 lys2D0 met15D0 trp1D63 ura3D0 ADE2-TEL-VR URA3-TEL-VIIL
ubp6::HIS3 ubp10::TRP1
This study
SQY1054 MAT  ade2D::hisG his3D200 leu2D0 lys2D0 met15D0 trp1D63 ura3D0 ADE2-TEL-VR URA3-TEL-VIIL
rad6::HIS3
This study
UCC6394 MAT  ade2D::hisG his3D200 leu2D0 lys2D0 met15D0 trp1D63 ura3D0 hta1-htb1::MET15 hta2-htb2::LEU2 ADE2-
TEL-VR URA3-TEL-VIIL pRG422
(14)
SQY1067 MAT  ade2D::hisG his3D200 leu2D0 lys2D0 met15D0 trp1D63 ura3D0 hta1-htb1::MET15 hta2-htb2::LEU2 ADE2-
TEL-VR URA3-TEL-VIIL pRG422 ubp6::TRP1
This study
SQY1068 MAT  ade2D::hisG his3D200 leu2D0 lys2D0 met15D0 trp1D63 ura3D0 hta1-htb1::MET15 hta2-htb2::LEU2 ADE2-
TEL-VR URA3-TEL-VIIL pRG422 ubp10::TRP1
This study
SQY1080 MAT  ade2D::hisG his3D200 leu2D0 lys2D0 met15D0 trp1D63 ura3D0 hta1-htb1::MET15 hta2-htb2::LEU2 ADE2-
TEL-VR URA3-TEL-VIIL pRG422 rad6::TRP1
This study
SQY1081 MAT  ade2D::hisG his3D200 leu2D0 lys2D0 met15D0 trp1D63 ura3D0 hta1-htb1::MET15 hta2-htb2::LEU2 ADE2-
TEL-VR URA3-TEL-VIIL pRG422 ubp6::TRP1 ubp10::LYS2
This study
SQY1086 MAT  ade2D::hisG his3D200 leu2D0 lys2D0 met15D0 trp1D63 ura3D0 hta1-htb1::MET15 hta2-htb2::LEU2 ADE2-
TEL-VR URA3-TEL-VIIL pRG422 sem1::TRP1
This study
SQY1088 MAT  ade2D::hisG his3D200 leu2D0 lys2D0 met15D0 trp1D63 ura3D0 hta1-htb1::MET15 hta2-htb2::LEU2 ADE2-
TEL-VR URA3-TEL-VIIL pRG422 sir2::TRP1
This study
SQY1089 MAT  ade2D::hisG his3D200 leu2D0 lys2D0 met15D0 trp1D63 ura3D0 hta1-htb1::MET15 hta2-htb2::LEU2 ADE2-
TEL-VR URA3-TEL-VIIL pRG422 ubp6::TRP1 Dsem1::LYS2
This study
CCFY101 W303–1A MAT  ade2–1 ura3–1 trp1–289 leu2–3,112 his3–11,15 can1–100 hmrDE::TRP1 rDNA::ADE2-CAN1
URA3-TEL-VR
(37) (38)
SQY1092 W303–1A MAT  ade2–1 ura3–1 trp1–289 leu2–3,112 his3–11,15 can1–100 hmrDE::TRP1 rDNA::ADE2-CAN1
URA3-TEL-VR ubp6::HIS3
This study
SQY1093 W303–1A MAT  ade2–1 ura3–1 trp1–289 leu2–3,112 his3–11,15 can1–100 hmrDE::TRP1 rDNA::ADE2-CAN1
URA3-TEL-VR sem1::HIS3
This study
SQY1094 W303–1A MAT  ade2–1 ura3–1 trp1–289 leu2–3,112 his3–11,15 can1–100 hmrDE::TRP1 rDNA::ADE2-CAN1
URA3-TEL-VR sir2::HIS3
This study
SQY1096 W303–1A MAT  ade2–1 ura3–1 trp1–289 leu2–3,112 his3–11,15 hmrDE::TRP1 rDNA::ADE2-CAN1 URA3-TEL-
VR sem1::HIS3 ubp6::LEU2
This study
SQY1103 MAT  ade2D::hisG his3D200 leu2D0 lys2D0 met15D0 trp1D63 ura3D0 ADE2-TEL-VR URA3-TEL-VIIL
pdr5::LEU2
This study
SQY1104 MAT  ade2D::hisG his3D200 leu2D0 lys2D0 met15D0 trp1D63 ura3D0 ADE2-TEL-VR URA3-TEL-VIIL
sem1::TRP1 ubp6::HIS3 pdr5::LEU2
This study
YAF182 MATa hta1-htb1::LEU2 hta2-htb2, ade2-1, ura3–1 trp1–289 leu2–3,112 his3–11, can1–100 GAPDH-HA-
UBI4::URA3<PZS145 HTA1-FLAG-HTB1, CEN, HIS3>
Osley
YAF183 MATa hta1-htb1::LEU2 hta2-htb2, ade2-1, ura3–1 trp1–289 leu2–3,112 his3–11, can1–100 GAPDH-HA-
UBI4::URA3<PZS145 HTA1-FLAG-htb1-K123R, CEN, HIS3>
Osley
SQY1107 MATa hta1-htb1::LEU2 hta2-htb2, ade2-1, ura3–1 trp1–289 leu2–3,112 his3–11, can1–100 GAPDH-HA-
UBI4::URA3<PZS145 HTA1-FLAG-htb1-K123R, CEN, HIS3> sem1::ADE2 ubp6::TRP1
This study
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tation with an anti-HA antibody (Convance). ChIP and
SeqChIP assays were replicated three times. PCR was used
to quantitate the amounts of immunoprecipitated DNA
fragments and input samples. Each PCR was performed
with cycling conditions as follows: 958C for 5min,
followed by 22 to 25 cycles consisting of 958C for
30s, 608C for 30s, and 728C for 1min. Optimal ampliﬁ-
cation in the linear range was empirically determined.
DNA bands were quantitated with Alpha Imager 2000
software. The primer sequences are available upon
request.
RESULTS AND DISCUSSION
Sem1pand Ubp6p participate in telomeric silencing
Telomeric silencing (also known as telomere position
eﬀect, TPE) refers to epigenetically repressed transcription
of a gene placed near the chromosome ends due to the
formation of heterochromatin-like structures at the telo-
meres (35). Telomeric silencing can be sensitively analyzed
with a reporter gene, i.e. URA3 or ADE2 integrated into
telomeric ends (36). Gene product of an URA3 gene at an
internal chromosomal site can convert 5-FOA into a
toxin, 50 ﬂuorouridine monophosphate, which severely
inhibits cellular growth. When URA3 is placed near a
telomere, its expression is repressed in 30–50%of cells
which will be able to grow in the presence of 5-FOA.
With the disruption of telomeric silencing, increased
expression of the telomeric URA3 will cause repressed cel-
lular growth in medium containing 5-FOA (35). Similarly,
Ade2p catalyzes a step in the de novo purine nucleotide
biosynthetic pathway. Yeast cells with an internal ADE2
form white colonies and deletion of ADE2 will cause accu-
mulation of P-ribosylamino imidazole which results in for-
mation of red color. Due to epigenetic repression, cells
with a telomeric ADE2 form red-sectored colonies.
To investigate the roles of Sem1p and Ubp6p in telo-
meric silencing, we deleted SEM1 or UBP6 in UCC606,
which contains an URA3 gene in the right end of chromo-
some VII and an ADE2 gene in the right end of chromo-
some V, and studied the corresponding eﬀect on the
expression of telomeric URA3 and ADE2. As shown in
Figure 1A, sem1D or ubp6D alone had slight repressive
eﬀect on cellular growth in the presence of 5-FOA.
However, deletion of SEM1 together with and UBP6
caused signiﬁcant sensitivity to 5-FOA. This suggests
that telomeric silencing is disrupted by simultaneous loss
of Sem1p and Ubp6p. Moreover, the 5-FOA sensitivity of
the sem1D ubp6D mutant was indistinguishable from that
induced by deleting SIR2 (Figure 1A). A screening study
of double mutants containing either sem1D or ubp6D and
deletion of a nonessential proteasomal gene failed to iden-
tify any signiﬁcant 5-FOA sensitivity (data not shown).
This indicated that the observed eﬀects of Sem1p and
Ubp6p in telomeric silencing are quite speciﬁc.
To test the validity of these eﬀects, sem1D ubp6D mutant
was transformed with a plasmid carrying wild-type copy
of SEM1 or UBP6 gene. Consequently, the mutant cells
containing these two plasmids were shown to once again
become resistant to 5-FOA (Figure 1A). This more direct
evidence demonstrates that speciﬁc expression of Sem1p
and Ubp6p in mutant background restores the wild-type
level of telomeric silencing. To exclude the possibility that
the 5-FOA sensitivity of the mutant cells is caused by the
toxic eﬀect of the drug, we spotted cells without telomeric
URA3 onto 5-FOA-containing medium. As expected, the
sem1D ubp6D mutant grew normally and did not exhibit
any 5-FOA sensitivity as compared to the wild-type (data
not shown).
We subsequently tested the yeast colony color change
caused by simultaneous loss of Sem1p and Ubp6p. As
shown in Figure 1B, a wild-type strain containing an inter-
nal ADE2 at a normal chromosomal site formed white
colonies on YPD medium. In contrast, UCC606, which
contains a telomeric ADE2, formed red-sectored colonies.
In addition, loss of Sem1p and Ubp6p in UCC606 caused
complete disappearance of the red pigmentation. As a
control, SIR2 deletion mutant, which is known to disrupt
telomeric silencing also resulted in the disappearance of
the red pigmentation in UCC606. The colony color change
induced by the loss of Sem1p and Ubp6p is consistent with
the 5-FOA sensitivity.
The preceding observation led us to investigate if Sem1p
and Ubp6p function together with Ubp10p, another deu-
biquitinating enzyme which is known to participate in
silencing at telomeres and HM loci (13,14). Ubp10p
exerts its eﬀect by increasing ubiquitinated-histone H2B
(ub-H2B) and disrupting the interaction between silencing
proteins and telomeres. Interestingly, ubp6D, but not
sem1D, was able to suppress the silencing defects caused
by ubp10D (Figure 1C). Besides, sem1D ubp6D ubp10D
mutant displayed partial 5-FOA sensitivity, which
suggested that ubp10D could in part rescue the
silencing defects caused by simultaneous deletion
of SEM1 and UBP6. These results indicated that interac-
tion among Ubp10p, Ubp6p and Sem1p maintain the
silencing status at telomeres, possibly by modulating
the histone H2B deubiquitination catalyzed by Ubp6p
and Ubp10p.
We then investigated the role of SEM1 and UBP6 in
the silencing of HM loci and rDNA arrays. For this pur-
pose, we used CCF101 , which contains a TRP1 in hmrDE
(HMR with E silencer removed) locus and an
ADE2-CAN1 cassette in the rDNA array (Figure 1D).
Expression of TRP1 and ADE2 can be assessed by mon-
itoring the cellular growth on medium lacking tryptophan
(SC-TRP) and adenine (SC-ADE), respectively.
Alternatively, color change due to de-repression of
ADE2 can be used for evaluating rDNA silencing.
Under normal conditions, HM loci are completely
silenced. Therefore, the E silencer was removed to
induce de-repression status. In the absence of Sem1p
and Ubp6p, the cellular growth on SC-TRP and SC-
ADE was severely inhibited (Figure 1D), demonstrating
the repression of TRP1 and ADE2 at both HMR locus
and rDNA array due to enhanced internal silencing. On
the other hand, SIR2 deletion induced a better cellular
growth (larger colony sizes) than wild-type cells on both
SC-TRP and SC-ADE plates. These observations
prompted us to speculate that Sem1p and Ubp6p are
1846 Nucleic Acids Research, 2009, Vol. 37,No. 6crucial in the formation of silencing machinery in the tel-
omere, or recruitment of silencing factors to the telomere,
but are not required for HM and rDNA silencing. These
results support a well-established model (37–39), in which
loss of silencing at telomeres results in relocation of silenc-
ing factors from telomeres to other genomic regions like
HM loci and rDNA array, and therefore causes enhanced
silencing at those loci.
WT
sem1D
ubp6D
sir2D
SC SC+ FOA A
sem1D ubp6D
B
   
 
ADE2-TEL-VR sem1D ubp6D sir2D
ADE2-TEL-VR
WT ade2D
sem1D ubp6D
+SEM1 + UBP6
ADE2-TEL-VR
SC SC-TRP SC-ADE
rDNA::ADE2 CAN1 D
TRP1 ADE2 CAN1
HM DER I 25S rDNA
C SC SC + FOA
WT
ubp6D
sir2D
sem1D ubp6D
sem1D
sem1D ubp10D
WT
ubp10D
ubp6D
ubp6D ubp10D
rad6D
HMRDE::TRP1
sem1D ubp6D ubp10D 
sem1D
Figure 1. Sem1p and Ubp6p participate in telomeric silencing. (A, B) Sem1p and Ubp6p are required for telomeric silencing. (C) Loss of Ubp6p
rescues silencing defects in the ubp10D mutant. (D) Sem1p and Ubp6p do not play a direct role in HM and rDNA silencing. Modiﬁed hmrDE locus
and rDNA array in CCFY101a were shown on the top. Sensitivity to 5-FOA was performed by spotting 10-fold serial dilutions of cells onto
synthetic complete (SC) plates and synthetic complete plates containing 0.1% 5-FOA (SC+FOA), respectively. The red/white colony color assay was
conducted by re-streaking cells on YPD plates. Plates were photographed after 5 to 7 days of growth at 308C. Genotypes of yeast strains are
indicated on the left. Assays were repeated three times. WT, wild-type.
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Participation of Sem1p and Ubp6p in the regulation of
telomeric silencing indicates that they either directly inﬂu-
ence the formation of silent chromatin in telomeres or
mediate the interaction between silencing factors and telo-
meric chromatin. To discern this, we ﬁrst investigated
whether Sem1p and Ubp6p physically associate with telo-
meres. Thus, SEM1, UBP6 and SIR2 were Myc-tagged
via PCR-based tagging method (32). The ChIP assay,
using a monoclonal anti-Myc antibody (Sigma), was
performed to analyze the interactions between these pro-
tein factors and the telomeric DNA sequences. Primers
for the ChIP experiments were designed using the DNA
sequences on the right end of chromosome VI (Figure 2A)
which shares the least homology to the rest of the yeast
genome. Our results show that both Sem1p (Figure 2B)
and Ubp6p (Figure 2C) were distinctly enriched at telo-
meres. Moreover, their association with telomere was
most signiﬁcant inside the 1-kb range, but almost disap-
peared at a 5-kb distance from the telomeric end
(Figure 2B and C). These results demonstrate that both
Sem1p and Ubp6p are physically associated with
telomere.
Next, we investigated the eﬀects of Sem1p and Ubp6p
on the association of Sir2p to the telomere. Deletion of
both SEM1 and UBP6 was observed to severely disrupt
Sir2p association with telomere (Figure 2D). Therefore,
Sem1p and Ubp6p are required for the physical interac-
tion between the silencing complex and telomere. Parallel
ChIP assay, however, revealed a manifold increase in the
association of Sir2p at HMR and rDNA loci in mutant
cells (Figure 2D). These combined observations presented
a direct evidence for relocation of silencing factors from
telomere to HM loci and rDNA array in the absence of
Sem1p and Ubp6p.
Dynamic equilibrium ofhistone H2B ubiquitination and
deubiquitination iscritical for telomeric silencing
Our data, showing that (i) ubp6D suppresses ubp10D-
induced defects in telomeric silencing (Figure 1C) and
(ii) the enrichment of Sem1p and Ubp6p at telomeres,
presuppose that Sem1p and Ubp6 along with Ubp10p
could be implicated in regulating H2B ubiquitination at
telomeres. To test this likelihood, we determined the cel-
lular levels of ubiquitinated-H2B (ub-H2B) in the presence
and absence of Sem1p and Ubp6p. Comparison of ub-
H2B levels in wild-type and mutant strains by western
blotting analysis, using anti-Flag M5 monoclonal anti-
body (Sigma) which speciﬁcally recognizes the Flag tag
attached to the N-terminus of H2B, showed a 1.8- and a
2.6-fold increase in ub-H2B in sem1D and ubp6D mutants,
respectively (Figure 3A). Moreover, simultaneous deletion
of SEM1 and UBP6 resulted in about 5-fold increase
in ub-H2B (Figure 3A). In contrast, transformation of
sem1D ubp6D mutant with plasmids carrying wild-type
SEM1 and UBP6, exhibited a reversal of ub-H2B to the
wild-type level (data not shown). These results demon-
strated that the loss of Sem1p and Ubp6p is clearly
responsible for the increased levels of ub-H2B in sem1D
ubp6D mutant. As a control, the band representing
ub-H2B completely disappeared in the rad6D mutant
(Figure 3A and B). Furthermore, Sir2p is known to func-
tion downstream of the core histone modiﬁcation step.
Accordingly, we also did not see any change in the ub-
H2B level in the sir2D strain (Figure 3A and B).
Interestingly, the increased ub-H2B level seen in either
the ubp6D or the ubp10D mutants was restored back
to the wild-type levels in the ubp6D ubp10D mutant
(Figure 3B). The simultaneous loss of Ubp6p and
Ubp10p might trigger the recruitment of another, yet
270000 260000
269000
265000
YFR055W YFR057W
YFR054C
VIR 5kb 1kb 10kb
A
D
2
4
6
0
C
h
I
P
/
I
n
p
u
t
GAL HMR rDNA TEL
WT
HA
NoAntibody
Sir2p-13Myc
B
C
h
I
P
/
I
n
p
u
t
0
2
4
6
GAL VIR 1kb 5kb  10kb
Sem1p-13Myc
GAL VIR 1kb 5kb 10kb
C
h
I
P
/
I
n
p
u
t
2
4
0
Ubp6p-13Myc C
sem1D ubp10D
Figure 2. Sem1p and Ubp6p associate with telomeres. (A) The ChIP
PCR regions in the right arm of chromosome VI are indicated by thick
solid bars at VIR, 1kb, 5kb and 10kb. Sem1p (B) and Ubp6p (C) are
recruited to telomere. (D) Deletion of SEM1 and UBP6 causes reloca-
tion of Sir2p from telomere to HM and rDNA loci. ChIP assays were
performed on samples from strains SQY1084 (Ubp6p-Myc), SQY1085
(Sem1p-Myc), SQY1090 (Sir2p-Myc) and SQY1091 (sem1::HIS3
ubp6::URA3 Sir2p-Myc). PCR fragments were generated with primers
speciﬁc to the GAL1-10 promoter, HMR locus and 25rDNA array,
DNA sequences at the right end of chromosome VI, and sequences
1, 5 or 10kb away from the telomeric end of chromosome VI.
Immunoprecipitation was performed using an anti-myc monoclonal
antibody (Upstate Biotechnology). An anti-HA monoclonal antibody
(Sigma) was used as a nonspeciﬁc antibody control. PCR products were
quantitated as described in ‘Materials and methods’ section. ChIP/input
values were obtained from the ratio of band intensities of immune-
recovered relative to input sample, which was normalized against the
ratios obtained with GAL1-10 promoter (GAL) (B and C) or wild-type
strain (D). GAL, GAL1-10 promoter. VIR, right end of chromosome
VI. WT, wild-type; HA, anti-HA antibody control.
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lowering ub-H2B to the wild-type level. This observation
is consistent with the phenotypic suppression of ubp10D-
indcued silencing defects by ubp6D (Figure 1C), and
suggested that Ubp6p and Ubp10p-dependent H2B deu-
biquitination are performing complementary functions.
Taken together, these data support the important role
of Sem1p, Ubp6p and Ubp10p-mediated histone H2B
deubiquitination in maintaining telomere silencing. It
can be surmised that Ubp6p- and Ubp10-dependent
H2B deubiquitination process spawns a dynamic balance
between H2B ubiquitination and deubiquitination that is
instrumental in regulating telomeric silencing. However,
a detailed mechanism of this process remains to be
elucidated.
We next examined the eﬀect on histone H2B ubiquiti-
nation induced by the loss of Sem1p and Ubp6p through
SeqChIP. In the wild-type cells, ub-H2B levels were lowest
at telomeric ends and showed a gradual increase at the
ChIP primer sites away from telomere (Figure 3C). For
instance at 10kb from telomere, ub-H2B level was more
than three times higher than at the ends. This wild-type
pattern of H2B ubiquitination is consistent with pre-
viously published reports that have shown the requirement
of Ubp10p for maintaining ub-H2B at low levels in the
proximity of telomeres (13). Loss of Ubp10p disrupted
this speciﬁc pattern of H2B ubiquitination. Similarly,
simultaneous loss of Sem1p and Ubp6p was also shown
here to disrupt the low ub-H2B levels in telomere. In con-
trast to wild-type cells, the sem1D ubp6D mutant had much
higher levels of ub-H2B in the telomere compared to the
10-kb distance from the telomeric end, consistent with the
results obtained in the ubp10D mutant (13). This reversed
pattern of telomeric H2B ubiquitination induced by the
loss of Sem1p and Ubp6p strongly suggests that Sem1p
and Ubp6p together with Ubp10p are intimately asso-
ciated in the maintenance of histone H2B ubiquitination
at the telomeric ends. In essence, a dynamic equilibrium
exists between ubiquitination catalyzed by Rad6p/Bre1p
and deubiquitination catalyzed by Ubp6p/Sem1p and
Ubp10p. These precisely regulated ub-H2B levels in turn
aid in tethering essential factors at telomeres to orches-
trate gene silencing.
Sem1pand Ubp6p participate in telomeric silencing by
regulatinghistone H3 K14/K23 acetylation
Acetylation of H3K14 and H3K23 is known to be a crit-
ical factor in telomeric silencing (17). Therefore, we inves-
tigated if the loss of Sem1p and Ubp6p aﬀects acetylation
by speciﬁc western blot analysis of a battery of acetylated
forms of histones H3 and H4. Compared to wild-type
cells, >3-fold decrease was seen in the acetylation of
H3K14 and H3K23 in the sem1D ubp6D mutant
(Figure 4A). On the other hand, acetylation levels of
H3K9 and H3K18 remained unchanged. We next exam-
ined H3K14 and H3K23 acetylation in the sem1D ubp6D
mutant carrying a plasmid containing the wild-type gene
SEM1 and UBP6, and found that H3K14 and H3K23 are
acetylated in the mutant as eﬃciently as the wild-type
(data not shown). Analysis of acetylation of lysine resi-
dues in the N-terminal tail of histone H4, which is also
known to impact telomeric silencing, did not show any
signiﬁcant changes at K5, K8, K12 and K16 moieties
(data not shown). Thus, Sem1p and Ubp6p mediate
their eﬀects by altering acetylation at speciﬁc sites of his-
tone H3, but not histone H4.
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Figure 3. Sem1p and Ubp6p regulate histone H2B ubiquitination.
(A) The sem1D ubp6D mutant shows increased level of histone H2B
ubiquitination. (B) Deletion of UBP10 in the ubp6D background
restores the level of ub-H2B back to that in the wild-type cells. A
plasmid copy of HTA1-FLAG-HTB1 was introduced into cells with
both HTA1-HTB1 and HTA2-HTB2 deleted from the genome.
(C) Sem1p and Ubp6p are involved in the regulation of H2B ubiquiti-
nation at telomere. Whole cell extracts were prepared from 25-ml cul-
tures in mid-log phase and 25mg protein were analyzed by western
blotting. To calculate the fold-change, the density of wild-type strain
was designated as 1.0, which was reset from the value obtained by
dividing the density of each band with the density of the corresponding
input band (H2B). SeqChIP was performed with anti-FLAG M5 and
anti-HA (Covance) antibodies. Relative IP represents the IP signal
normalized to the respective input signal and then to the respective
background signal obtained from the yeast strain with K123R muta-
tion. Densities of protein and DNA bands were quantitated as
described in ‘Materials and methods’ section. Standard deviations
were calculated from three replicates. Genotypes of yeast strains are
indicated on the top. NT, non-tagged.
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H3K23 is exclusively occurring at the telomeric histones,
and thus, is required for silencing at telomeres, we ana-
lyzed the acetylation pattern of H3K14 and H3K23 at
telomeres via the ChIP assay. The results showed that
acetylated-H3K14 and H3K23 were reduced >3-fold at
the right telomeric end of chromosome VI in the sem1D
ubp6D mutant (Figure 4B). However, there was no signif-
icant change in H3K9 acetylation in the sem1D ubp6D
mutant in comparison to wild-type cells. These results
are fully consistent with western blot analysis
(Figure 4A), and conﬁrmed that Sem1p and Ubp6p are
required for acetylation of H3K14 and H3K23 in telo-
mere. Finally, consistent with the results of Figures 1C
and 3B, the ubp6D ubp10D mutant acetylated H3K14
and H3K23 as eﬃciently as the wild-type cells
(Figure 4C). Therefore, histone H3 acetylation mediated
by Sem1p and Ubp6p participates in telomeric silencing,
and functions in a diﬀerent pathway than that of the
Ubp10 ubiquitin protease.
We also determined if the acetylation of H3K14 and
H3K23 is the direct result of Sem1p and Ubp6p activities
in yeast. For this purpose, the sem1D ubp6D mutant cells
were transformed with two plasmids expressing the wild-
type Sem1p and Ubp6p and their extracts were analyzed
by western blot and ChIP assays. Introduction of the two
activities into the sem1D ubp6D mutant restored the H3
K14 and K23 acetylation back to the wild-type level
(Figure 4B). These results conﬁrmed that the defect in
H3 acetylation is directly dependent on the loss of
Sem1p and Ubp6p function. Collectively, our data
reveal that enhanced H2B ubiquitination and accompany-
ing reduction in H3K14 and H3K23 acetylation levels
account for the silencing defects in the absence of Sem1p
and Ubp6p at telomere. At this point, however, it is not
entirely clear how H2B deubiquitination signals histone
H3K14 and H3K23 acetylation, but both these events
require participation of Sem1p and Ubp6p.
Sem1p andUbp6p maintain telomeric silencing
independently ofthe proteolytic degradation
As functional components of the proteasome, Sem1p and
Ubp6p could impart their eﬀect on gene expression inde-
pendently or through proteasome-dependent proteolysis.
To resolve this, we ﬁrst determined the involvement of
these two proteins in the protein degradation pathway.
Thus, arginine in the synthetic media was replaced with
canavanine, a nonproteinogenic analog of arginine. In this
medium, cells are forced to take up canavanine instead of
arginine to support their protein synthesis. However, the
incorporation of canavanine into the polypeptide chain
results in synthesis of abnormal protein products, which
can accumulate if the ubiquitin-proteasome pathway is
rendered defective. Consequently, accumulation of indi-
gestible protein products prevents normal cellular
growth and causes cell death. Both sem1D and ubp6D
are known to induce sensitivity to high concentrations of
canavanine (27,29). However, under our assay conditions
using a lower (1mg/ml) concentration, neither sem1D nor
ubp6D showed any discernable sensitivity to canavanine.
Yet, at this low concentration, simultaneous deletion of
SEM1 and UBP6 caused a dramatic growth defect in the
presence of canavanine (Figure 5A). This suggests that
Sem1p and Ubp6p function cooperatively to undertake
eﬃcient proteolysis for sustaining cell survival.
To ascertain the uniqueness of silencing eﬀect and any
impact of proteolysis, we investigated the changes of spe-
ciﬁc gene transcription in response to SEM1 and UBP6
deletion under conditions of inhibited proteasomal
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of Sem1p and Ubp6p results in reduced acetylation of K14 and K23 on
histone H3. (B) Deletion of SEM1 and UBP6 causes reduction of H3
K14 and K23 acetylation in the telomere. (C) The ubp6D ubp10D
mutant is able to acetylate K14 and K23. Global steady-state levels
of acetylation of diﬀerent residues were determined using site-speciﬁc
antibodies. Western blotting analysis and quantitation were performed
as described for Figure 3. The ChIP assay was performed as described
for Figure 2. Standard deviations were calculated from three replicates.
Genotypes of yeast strains are indicated on the top. VIR, right end of
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were made sensitive to the uptake of Velcade analog
MG-132 by deletion of their pdr5 gene. These sensitized
strains were used for gene expression studies using RT-
PCR assay (Figure 5B). As expected, transcription of a
constitutive gene, ACT1, was not sensitive to either simul-
taneous deletion of SEM1 and UBP6 or the MG-132
treatment. Consistent with previous reports (24), tran-
scription of HIS4 and CPA2 was signiﬁcantly reduced in
the presence of MG-132. In addition, loss of Sem1p and
Ubp6p also negatively aﬀected the HIS4 and CPA2 tran-
scription, but to a lesser extent. The negative eﬀects on
HIS4 and CPA2 transcription induced by MG-132 treat-
ment and simultaneous deletion of SEM1 and UBP6 were
additive. However, expression of telomeric URA3 and
ADE2 showed a >3-fold increase in response to the simul-
taneous loss of Sem1p and Ubp6p, albeit as seen with
HIS4 and CPA2, their transcription was also reduced by
MG-132 treatment. More importantly, a 2-fold decrease
in telomeric URA3 and ADE2 expression induced by MG-
132 could not completely reverse the strong de-repressing
eﬀect due to the loss of Sem1p and Ubp6p (Figure 5B).
This diﬀerential response of telomeric URA3 and ADE2
suggests that gene silencing regulated by Sem1p and
Ubp6p is independent from that of Sem1p and Ubp6p-
dependent protein degradation.
Based upon the overall results of this study, a
simpliﬁed scheme is presented to illustrate the mechanics
of Sem1p and Ubp6p participation in telomeric silencing
(Figure 6). According to this model, Sem1p and Ubp6p
regulate a major catalytic force that deubiquitinates his-
tone H2B. Ubp6p is activated by interacting with Sem1p
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Nucleic Acids Research,2009, Vol.37, No. 6 1851and its activation untangles a delicate equilibrium between
ubiquitination and deubiquitination of H2B. This disequi-
librium translates into a speciﬁc acetylation pattern of H3
K14 and K23, which is essential for the maintenance of
silent chromatins at telomeres. Simultaneous deletion of
SEM1 and UBP6 is shown to disrupt this tightly regulated
equilibrium between H2B ubiquitination and deubiquiti-
nation, and compromise the acetylation pattern of H3
K14 and K23. These changes, in turn, result in reduced
recruitment of silencing protein factors and disruption of
silent chromatin at telomere. The silencing factors released
from telomere promptly redistribute to other genomic
regions, i.e. HM and rDNA loci, causing increased levels
of gene silencing at these sites. Taken together, our results
provide a new regulatory pathway of telomeric silencing
by the proteasome-associated Ubp6p and Sem1p.
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